Dora Bodnar is a top-performing research professional in the biopharmaceutical industry, specializing in target identification and assay development with a focus on advancing research in neuromuscular and muscle diseases. From 2017 to 2020, they served as a Research Fellow at Harvard Medical School, where they explored calcium homeostasis dysfunction linked to various myopathies. At Biogen, from 2020 to 2025, they built muscle research tools and established disease models for target identification and efficacy studies. Currently, as a Senior Scientist II at UCB since 2025, they continue to contribute to the field. Dora holds a PhD in Molecular Biology and has additional Master's degrees in Food Safety and Quality Engineering as well as Molecular Biology from the University of Debrecen.
This person is not in the org chart
This person is not in any teams
This person is not in any offices